CollPlant Biotechnologies Ltd. (CLGN) vs Dermata Therapeutics, Inc. (DRMA)
A side-by-side comparison of CollPlant Biotechnologies Ltd. and Dermata Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CLGN
CollPlant Biotechnologies Ltd.
$3.41HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
DRMA
Dermata Therapeutics, Inc.
$1.11HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
Total return — CLGN vs DRMA
growth of $100 · dividends reinvested · last 5yCLGN -98.2% (-55.1%/yr)DRMA -100.0% (-84.5%/yr)CLGN compounded faster over this window
Log scale — wide-divergence pair
CLGN DRMA
CLGN vs DRMA: by the numbers
- •DRMA is the larger company ($4M vs $4M market cap).
- •Both run net losses; DRMA's is the smaller (0.00% vs -3934.91% net margin).
Metrics side by side
Valuation
| Metric | CLGN | DRMA |
|---|---|---|
| P/S ratio | 13.90 | N/A |
| P/B ratio | 1.50 | 1.28 |
Profitability
| Metric | CLGN | DRMA |
|---|---|---|
| Gross margin | 26.32% | 0.00% |
| Operating margin | -484.31% | 0.00% |
| Net margin | -3934.91% | 0.00% |
| ROE | -424.89% | -239.95% |
| ROIC | -221.32% | -246.61% |
Growth (annualized)
| Metric | CLGN | DRMA |
|---|---|---|
| Revenue CAGR (5Y) | -56.28% | N/A |
| Total return CAGR (5Y) | -53.69% | -83.90% |
Frequently asked
- How have CLGN and DRMA total returns compared?
- Over the past 5 years, CLGN delivered -53.69% and DRMA delivered -83.90% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.